Advanced search
Publication Cover
Expert Review of Vaccines Volume 13, 2014 - Issue 1
Submit an article Journal homepage
158
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Comorbid risk, respondent characteristics and likelihood of pneumococcal vaccination versus no vaccination among older adults in Brazil

Amir GorenHealth Outcomes Practice, Kantar Health, 11 Madison Ave, Fl 12, New York, NY 10010, USACorrespondence[email protected]
,
Craig RobertsHealth Economics and Outcomes Research, Emerging Markets Business Unit, Pfizer Inc., 500 Arcola Road, Collegeville, PA 19426, USA
&
Timothy W VictorScience and Strategy, Kantar Health, 1 Independence Way, Princeton, NJ 08540, USA
Pages 175-184 | Published online: 04 Dec 2013

References

  • World Health Organization. 23-valent pneumococcal polysaccharide vaccine. WHO position paper. Wkly Epidemiol. Rec. 83(42), 373–384 (2008).
  • World Health Organization. Pneumococcal vaccines WHO position paper – 2012. Wkly Epidemiol. Rec. 87, 12–144 (2012).
  • Weycker D, Strutton D, Edelsberg J, Sato R, Jackson LA. Clinical and economic burden of pneumococcal disease in older US adults. Vaccine 28(31), 4955–4960 (2010).
  • Huang SS, Johnson KM, Ray GT et al. Healthcare utilization and cost of pneumococcal disease in the United States. Vaccine 29(18), 3398–3412 (2011).
  • Isturiz RE, Luna CM, Ramirez J. Clinical and economic burden of pneumonia among adults in Latin America. Int. J. Infect. Dis. 14(10), e852–e856 (2010).
  • Lynch JP 3rd, Zhanel GG. Streptococcus pneumoniae: epidemiology, risk factors, and strategies for prevention. Semin. Respir. Crit. Care Med. 30(2), 189–209 (2009).
  • Kyaw MH, Rose CE Jr, Fry AM et al. The influence of chronic illnesses on the incidence of invasive pneumococcal disease in adults. J. Infect. Dis. 192(3), 377–386 (2005).
  • World Health Organization. Pneumococcal vaccines WHO position paper - 2012 - recommendations. Vaccine 30(32), 4717–4718 (2012).
  • Dower J, Donald M, Begum N, Vlack S, Ozolins I. Patterns and determinants of influenza and pneumococcal immunisation among adults with chronic disease living in Queensland, Australia. Vaccine 29(16), 3031–3037 (2011).
  • Klabunde CN, Meissner HI, Wooten KG, Breen N, Singleton JA. Comparing colorectal cancer screening and immunization status in older Americans. Am. J. Prev. Med. 33(1), 1–8 (2007).
  • Nowalk MP, Zimmerman RK, Tabbarah M, Raymund M, Jewell IK. Determinants of adult vaccination at inner-city health centers: a descriptive study. BMC Fam. Pract. 7, 2 (2006).
  • Neto JT, de Araujo GT, Gagliardi A, Pinho A, Durand L, Fonseca M. Cost-effectiveness analysis of pneumococcal polysaccharide vaccination from age 60 in Sao Paulo State, Brazil. Hum. Vaccin. 7(10), 1037–1047 (2011).
  • Farmer GC, Papachristou T, Gotz C, Yu F, Tong D. Does primary language influence the receipt of influenza and pneumococcal immunizations among community-dwelling older adults? J. Aging. Health 22(8), 1158–1183 (2010).
  • Madhavan SS, Borker RD, Fernandes AW, Amonkar MM, Rosenbluth SA. Assessing predictors of influenza and pneumonia vaccination in rural senior adults. J. Health Soc. Policy 18(4), 13–38 (2004).
  • Zimmerman RK, Santibanez TA, Fine MJ et al. Barriers and facilitators of pneumococcal vaccination among the elderly. Vaccine 21(13–14), 1510–1517 (2003).
  • Zimmerman RK, Tabbarah M, Nowalk MP et al. Predictors of pneumococcal polysaccharide vaccination among patients at three inner-city neighborhood health centers. Am. J. Geriatr. Pharmacother. 3(3), 149–159 (2005).
  • Krueger P, St Amant O, Loeb M. Predictors of pneumococcal vaccination among older adults with pneumonia: findings from the Community Acquired Pneumonia Impact Study. BMC Geriatr. 10, 44 (2010).
  • Looijmans-van den Akker I, van den Heuvel PM, Verheij TJ, van Delden JJ, van Essen GA, Hak E. No intention to comply with influenza and pneumococcal vaccination: behavioural determinants among smokers and non-smokers. Prev. Med. 45(5), 380–385 (2007).
  • Bardenheier BH, Shefer A, McKibben L, Roberts H, Rhew D, Bratzler D. Factors predictive of increased influenza and pneumococcal vaccination coverage in long-term care facilities: the CMS-CDC standing orders program Project. J. Am. Med. Dir. Assoc. 6(5), 291–299 (2005).
  • Opstelten W, Hak E, Verheij TJ, van Essen GA. Introducing a pneumococcal vaccine to an existing influenza immunization program: vaccination rates and predictors of noncompliance. Am. J. Med. 111(6), 474–479 (2001).
  • Arslan I, Beyazova U, Aksakal N, Polat S, Camurdan AD, Sahin F. New opportunity for vaccinating older people: well-child clinic visits. Pediatr. Int. 54(1), 45–51 (2012).
  • Laguardia J, Campos MR, Travassos CM, Najar AL, Anjos LA, Vasconcellos MM. Psychometric evaluation of the SF-36 (v.2) questionnaire in a probability sample of Brazilian households: results of the survey Pesquisa Dimensoes Sociais das Desigualdades (PDSD), Brazil, 2008. Health Qual. Life Outcomes 9, 61 (2011).
  • Ware JEJ, Kosinski M, Turner-Bowker D, Gandek B. User’s Manual for the SF-12v2™ Health Survey with a Supplement Documenting SF-12® Health Survey. QualityMetric Incorporated, Lincoln, RI, USA (2002).
  • Cavalheiro LM, Gil JA, Goncalves RS, Pacheco MP, Ferreira PL, Fa L. Measuring the pain impact in adults with a chronic pain condition: adaptation and validation of the Pain Impact Questionnaire (PIQ-6) to the Portuguese culture. Pain Med. 12(10), 1538–1543 (2011).
  • Ferreira-Valente MA, Pais-Ribeiro JL, Jensen MP. Psychometric properties of the portuguese version of the Pain Self-Efficacy Questionnaire. Acta Reumatol. Port. 36(3), 260–267 (2011).
  • Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics 4(5), 353–365 (1993).
  • Ciconelli RM, Soarez PC, Kowalski CC, Ferraz MB. The Brazilian Portuguese version of the Work Productivity and Activity Impairment: General Health (WPAI-GH) questionnaire. Sao Paulo Med. J. 124(6), 325–332 (2006).
  • Fletcher MJ, Upton J, Taylor-Fishwick J et al. COPD uncovered: an international survey on the impact of chronic obstructive pulmonary disease [COPD] on a working age population. BMC Public Health 11, 612 (2011).
  • Ehresmann KR, Ramesh A, Como-Sabetti K, Peterson DC, Whitney CG, Moore KA. Factors associated with self-reported pneumococcal immunization among adults 65 years of age or older in the Minneapolis-St. Paul metropolitan area. Prev. Med. 32(5), 409–415 (2001).
  • Santibanez TA, Nowalk MP, Zimmerman RK et al. Knowledge and beliefs about influenza, pneumococcal disease, and immunizations among older people. J. Am. Geriatr. Soc. 50(10), 1711–1716 (2002).
  • Harris LM, Chin NP, Fiscella K, Humiston S. Barrier to pneumococcal and influenza vaccinations in Black elderly communities: mistrust. J. Natl Med. Assoc. 98(10), 1678–1684 (2006).
  • Mascarenhas OA, Cardozo LJ, Afonso NM et al. Hypothesized predictors of patient-physician trust and distrust in the elderly: implications for health and disease management. Clin. Interv. Aging 1(2), 175–188 (2006).
  • Castaneda-Orjuela C, Alvis-Guzman N, Paternina AJ, De la Hoz-Restrepo F. Cost-effectiveness of the introduction of the pneumococcal polysaccharide vaccine in elderly Colombian population. Vaccine 29(44), 7644–7650 (2011).
  • Rozenbaum MH, Hak E, van der Werf TS, Postma MJ. Results of a cohort model analysis of the cost-effectiveness of routine immunization with 13-valent pneumococcal conjugate vaccine of those aged > or =65 years in the Netherlands. Clin. Ther. 32(8), 1517–1532 (2010).
  • Smith KJ, Wateska AR, Nowalk MP, Raymund M, Nuorti JP, Zimmerman RK. Cost-effectiveness of adult vaccination strategies using pneumococcal conjugate vaccine compared with pneumococcal polysaccharide vaccine. JAMA 307(8), 804–812 (2012).
  • Huss A, Scott P, Stuck AE, Trotter C, Egger M. Efficacy of pneumococcal vaccination in adults: a meta-analysis. CMAJ 180(1), 48–58 (2009).
  • Moberley SA, Holden J, Tatham DP, Andrews RM. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst. Rev. (1), CD000422 (2008).
  • Andrews NJ, Waight PA, George RC, Slack MP, Miller E. Impact and effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in the elderly in England and Wales. Vaccine 30(48), 6802–6808 (2012).
  • Shapiro ED, Berg AT, Austrian R et al. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N. Engl. J. Med. 325(21), 1453–1460 (1991).
  • Torling J, Hedlund J, Konradsen HB, Ortqvist A. Revaccination with the 23-valent pneumococcal polysaccharide vaccine in middle-aged and elderly persons previously treated for pneumonia. Vaccine 22(1), 96–103 (2003).
  • Stein KE. Thymus-independent and thymus-dependent responses to polysaccharide antigens. J Infect. Dis. 165( Suppl. 1), S49–S52 (1992).
  • Nurkka A, Ahman H, Korkeila M, Jantti V, Kayhty H, Eskola J. Serum and salivary anti-capsular antibodies in infants and children immunized with the heptavalent pneumococcal conjugate vaccine. Pediatr. Infect. Dis. J. 20(1), 25–33 (2001).
  • Weycker D, Sato R, Strutton D, Edelsberg J, Atwood M, Jackson LA. Public health and economic impact of 13-valent pneumococcal conjugate vaccine in US adults aged >/=50 years. Vaccine 30(36), 5437–5444 (2012).
  • Hak E, Grobbee DE, Sanders EA et al. Rationale and design of CAPITA: a RCT of 13-valent conjugated pneumococcal vaccine efficacy among older adults. Neth. J. Med. 66(9), 378–383 (2008).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.